-
CSR Summary Not Available
-
NCT04021862
-
Primary Citation Trial has yet to be published
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameBermekimabProduct NameN/ATherapeutic AreaImmune System DiseasesEnrollment86% FemaleN/A% WhiteN/A
Product ClassMonoclonal AntibodySponsor Protocol Number77474462ADM2002Data PartnerJohnson & JohnsonCondition StudiedDermatitis, AtopicMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available